Evaluation of the Carba NP test in Oregon, 2013

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 1, 2017, Pages

  Morey, Karim E ^a   Vega, Robert ^a   Cassidy, P Maureen ^b   Buser, Genevieve L ^b   Rayar, Jaipreet K ^c   Myers, Jeffrey A ^c   Weissman, Scott J ^c   Beldavs, Zintars G ^b   Pfeifferd, Christopher D ^d,e  

^a Oregon State Public Health   (United States)

^b OREGON HEALTH AUTHORITY   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Carba NP; Carbapenemase; IMP; KPC; NDM; OXA 48; VIM

Indexed keywords

AMIKACIN; CARBAPENEMASE; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; CARBA NP TEST; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CITROBACTER AMALONATICUS; CITROBACTER BRAAKII; CITROBACTER FREUNDII; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER ASBURIAE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HAFNIA ALVEI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA; MORGANELLA MORGANII; NONHUMAN; OREGON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS STUTZERI; RAOULTELLA ORNITHINOLYTICA; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS; CLASSIFICATION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 85009289181     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03005-15     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/threat-report-2013/. Accessed 29 April 2014.
2. Mathers AJ, Carroll J, Sifri CD, Hazen KC. 2013. Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. J Clin Microbiol 51:1291-1293. https://doi.org/10.1128/JCM.03240-12.
3. Carvalhaes CG, Picao RC, Nicoletti AG, Xavier DE, Gales AC. 2010. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 65:249-251. https://doi.org/10.1093/jac/dkp431.
4. Seah C, Low DE, Patel SN, Melano RG. 2011. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J Clin Microbiol 49:1965-1969. https://doi.org/10.1128/JCM.00203-11.
5. Pfeiffer CD, Cunningham MC, Poissant T, Furuno JP, Townes JM, Leitz A, Thomas A, Buser GL, Arao RF, Beldavs ZG. 2014. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region. Infect Control Hosp Epidemiol 35:356-361. https://doi.org/10.1086/675605.
6. Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler VG, Jr, Moehring RW, Chen LF, Jones CD, Moore ZS, Sexton DJ, Anderson DJ. 2014. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 35:978-983. https://doi.org/10.1086/677157.
7. Girlich D, Poirel L, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 50:477-479. https://doi.org/10.1128/JCM.05247-11.
8. Nordmann P, Poirel L, Dortet L. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 18:1503-1507. https://doi.org/10.3201/eid1809.120355.
9. Vasoo S, Cunningham SA, Kohner PC, Simner PJ, Mandrekar JN, Lolans K, Hayden MK, Patel R. 2013. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol 51:3097-3101. https://doi.org/10.1128/JCM.00965-13.
10. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Dortet L, Brechard L, Cuzon G, Poirel L, Nordmann P. 2014. Strategy for rapid detection of carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 58:2441-2445. https://doi.org/10.1128/AAC.01239-13.
12. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. 2013. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:4578-4580. https://doi.org/10.1128/AAC.00878-13.
13. Osterblad M, Hakanen AJ, Jalava J. 2014. Evaluation of the Carba NP test for carbapenemase detection. Antimicrob Agents Chemother 58:7553-7556. https://doi.org/10.1128/AAC.02761-13.
14. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. 2014. Reply to "Further proofs of concept for the Carba NP test." Antimicrob Agents Chemother 58:1270. https://doi.org/10.1128/AAC.02285-13.
15. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. 2013. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 57:130-136. https://doi.org/10.1128/AAC.01686-12.
16. Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, Sifri CD. 2013. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol 51:680-683. https://doi.org/10.1128/JCM.02580-12.
17. Mataseje LF, Boyd DA, Hoang L, Imperial M, Lefebvre B, Miller M, Poutanen SM, Roscoe D, Willey BM, Mulvey MR. 2013. Carbapenem-hydrolyzing oxacillinase-48 and oxacillinase-181 in Canada, 2011. Emerg Infect Dis 19:157-160. https://doi.org/10.3201/eid1901.120706.
18. Centers for Disease Control and Prevention. 2015. Tracking CRE. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html. Accessed 13 July 2016.